作者: Henrietta Nittby , Peter Ericsson , Karolina Förnvik , Susanne Strömblad , Linda Jansson
DOI: 10.1371/JOURNAL.PONE.0071981
关键词:
摘要: Coping with the immune rejection of allotransplants or autologous cells in patients an active sensitization towards their autoantigens and autoimmunity presently necessitates life-long suppressive therapy acting on system as a whole, which makes vulnerable to infections increases risk developing cancer. New technologies induce antigen selective long-lasting immunosuppression tolerance are therefore much needed.